top of page
IP Valuation of Gene Therapy Biotech Company
The AMCO Approach
We reviewed the firm’s patents, clinical trial data, and proprietary gene-editing technologies. Our valuation accounted for the therapy’s market potential, competitive landscape, and regulatory considerations within gene therapy.
Client Outcome
The robust IP valuation enabled the biotech firm to attract major investment, securing funding needed for clinical trials and advancing towards regulatory approval.
Instruction
AMCO was instructed by a biotechnology firm focused on gene therapy solutions to value its IP portfolio. The company needed an independent valuation for fundraising purposes as it prepared for clinical trials of its flagship treatment.
Contact Us
AMCO Agency Limited
First Floor
85 Great Portland Street
London
W1W 7LT
+44 7973 600 500
bottom of page